Cargando…
Assessing nanoparticle risks to human health /
The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risk...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Waltham, MA :
William Andrew,
�2011.
|
| Colección: | Micro & nano technologies.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn749852784 | ||
| 003 | OCoLC | ||
| 005 | 20231117044620.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 110906s2011 mau ob 001 0 eng d | ||
| 010 | |a 2011293452 | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d UKMGB |d N$T |d CDX |d TEF |d OCLCQ |d COO |d OCLCO |d UMI |d DEBBG |d DEBSZ |d YDXCP |d IDEBK |d OCLCQ |d OPELS |d OCLCQ |d UAB |d OCLCQ |d CASUM |d OCLCO |d OCLCA |d U3W |d OCLCO |d CEF |d WYU |d OCLCO |d OCLCA |d LEAUB |d ESU |d STF |d OCLCO |d VT2 |d OCLCA |d OCLCO |d OCLCF |d OCLCQ |d OCLCO | ||
| 016 | 7 | |a 015826248 |2 Uk | |
| 019 | |a 751698172 |a 816860342 |a 823130125 |a 823853487 |a 823923903 |a 824104397 |a 858681727 |a 916427002 |a 1066051613 |a 1103282634 | ||
| 020 | |a 9781437778632 |q (electronic bk.) | ||
| 020 | |a 1437778631 |q (electronic bk.) | ||
| 020 | |z 9781437778649 | ||
| 020 | |z 143777864X | ||
| 035 | |a (OCoLC)749852784 |z (OCoLC)751698172 |z (OCoLC)816860342 |z (OCoLC)823130125 |z (OCoLC)823853487 |z (OCoLC)823923903 |z (OCoLC)824104397 |z (OCoLC)858681727 |z (OCoLC)916427002 |z (OCoLC)1066051613 |z (OCoLC)1103282634 | ||
| 050 | 4 | |a RS201.N35 |b A87 2011eb | |
| 072 | 7 | |a MED |x 003040 |2 bisacsh | |
| 072 | 7 | |a MED |x 009000 |2 bisacsh | |
| 072 | 7 | |a MED |x 029000 |2 bisacsh | |
| 072 | 7 | |a MED |x 048000 |2 bisacsh | |
| 072 | 7 | |a TEC |x 059000 |2 bisacsh | |
| 082 | 0 | 4 | |a 610.28 |2 23 |
| 245 | 0 | 0 | |a Assessing nanoparticle risks to human health / |c Gurumurthy Ramachandran, editor. |
| 260 | |a Waltham, MA : |b William Andrew, |c �2011. | ||
| 300 | |a 1 online resource (xvii, 280 pages). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Micro & nano technologies series | |
| 520 | |a The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risks in this context. It will consider the occupational environment where the potential for human exposure is the greatest as well as the issues relevant to occupational exposure assessment (e.g., the exposure metric) and the evidence from toxicological and epidemiological studies. A chapter will be devoted to how conventional risk assessment can be carried out for a candidate nanoparticle (e.g., carbon nanotubes), and the limitations that arise from this approach. We will propose several alternate methods in another chapter including screening assessments and adapting the rich methodological literature on the use of experts for risk assessment. Another chapter will deal with non-occupational populations, their susceptibilities, and life-cycle risk assessments. There will be a chapter on current risk management and regulatory oversight frameworks and their adequacy. This chapter will also include a discussion of US and EU approaches to risk assessment, as well as corporate approaches. | ||
| 505 | 0 | |a Assessing Exposures to Nanoparticles in the Occupational Environment -- Nanotoxicology and human health effects of Nanoparticles -- Risk Assessment Case Study for Example Engineered Nanoparticles -- Using Expert Judgment for Risk Assessment -- Non-Occupational Population Risks and their Management -- Oversight and Regulation of Risks. | |
| 504 | |a Includes bibliographical references and index. | ||
| 650 | 0 | |a Nanoparticles |x Risk assessment. | |
| 650 | 0 | |a Risk assessment. | |
| 650 | 0 | |a Human beings. | |
| 650 | 1 | 2 | |a Environmental Exposure |x adverse effects |0 (DNLM)D004781Q000009 |
| 650 | 1 | 2 | |a Nanoparticles |x adverse effects |0 (DNLM)D053758Q000009 |
| 650 | 2 | 2 | |a Risk Assessment |0 (DNLM)D018570 |
| 650 | 0 | 2 | |a Humans |0 (DNLM)D006801 |
| 650 | 6 | |a Nanoparticules |0 (CaQQLa)201-0262530 |x �Evaluation du risque. |0 (CaQQLa)201-0385652 | |
| 650 | 6 | |a �Evaluation du risque. |0 (CaQQLa)201-0139195 | |
| 650 | 6 | |a �Etres humains. |0 (CaQQLa)201-0020070 | |
| 650 | 7 | |a risk assessment. |2 aat |0 (CStmoGRI)aat300263660 | |
| 650 | 7 | |a Homo sapiens (species) |2 aat |0 (CStmoGRI)aat300265711 | |
| 650 | 7 | |a MEDICAL |x Allied Health Services |x Medical Technology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Biotechnology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Family & General Practice. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Lasers in Medicine. |2 bisacsh | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING |x Biomedical. |2 bisacsh | |
| 650 | 7 | |a Risk assessment |2 fast |0 (OCoLC)fst01098146 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Ramachandran, Gurumurthy, |d 1963- | |
| 830 | 0 | |a Micro & nano technologies. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781437778632 |z Texto completo |